ZEPPN Stock Chart & Stats
$254.00
$0.00(0.00%)
At close: 4:00 PM EDT
$254.00
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$70.00 - $411.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$1.15B
Enterprise Value$325.95
Total Cash (Recent Filing)$709.95M
Total Debt (Recent Filing)$1.65B
Price to Earnings (P/E)―
Beta-0.47
Next Earnings
Aug 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-217.85
Shares Outstanding8,460,126
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.02
Price to Sales (P/S)0.01
P/FCF Ratio-0.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Sustained Revenue GrowthStrong, broad-based top-line growth driven by new product launches indicates improving market traction and expanding customer adoption. Durable revenue expansion helps absorb fixed costs, supports scale benefits, and underpins a multi-quarter path to profitability if margins and mix hold.
Premiumization / ASP ExpansionA sustained rise in ASPs from premium models improves unit economics and supports higher gross margins over time. Premiumization reflects brand strength and pricing power, which can provide a structural margin buffer versus pure volume plays and help the company move toward sustainable profitability.
Strategic Ecosystem Partnership (HYROX)A multi-year partnership with HYROX expands product adjacencies and integrates workout-specific features, strengthening differentiation and ecosystem lock-in. This structural collaboration can drive customer engagement, cross-sell opportunities, and long-term monetization beyond standalone device sales.
Bears Say
Persistent Net LossesMeaningful, ongoing net losses reduce retained earnings and return profiles, limiting the company's ability to self-fund growth and increasing reliance on external capital. Continued losses constrain strategic flexibility and extend the timeline for generating positive ROIC absent steady margin improvement.
Negative Free Cash Flow / Inconsistent Cash GenerationIntermittent and negative free cash flow undermines financial resilience, forcing dependence on financing or cash reserves to fund operations. Without consistent positive cash generation, the company faces higher funding risk and reduced capacity for sustained product investment or marketing over multiple quarters.
Rising Leverage And Short-term Debt ExposureLeverage increasing to slightly above equity and reclassification of borrowings to short term raise refinancing and liquidity risk. Higher leverage limits strategic options, increases interest sensitivity, and magnifies downside if cash flow or margins deteriorate during industry cost pressure cycles.
Zepp Health News
ZEPPN FAQ
What was Zepp Health Corporation’s price range in the past 12 months?
Zepp Health Corporation lowest stock price was $70.00 and its highest was $411.00 in the past 12 months.
What is Zepp Health Corporation’s market cap?
Zepp Health Corporation’s market cap is $1.15B.
When is Zepp Health Corporation’s upcoming earnings report date?
Zepp Health Corporation’s upcoming earnings report date is Aug 26, 2026 which is in 24 days.
How were Zepp Health Corporation’s earnings last quarter?
Zepp Health Corporation released its earnings results on Jun 09, 2026. The company reported -$1.214 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Zepp Health Corporation overvalued?
According to Wall Street analysts Zepp Health Corporation’s price is currently Overvalued.
Does Zepp Health Corporation pay dividends?
Zepp Health Corporation does not currently pay dividends.
What is Zepp Health Corporation’s EPS estimate?
Zepp Health Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zepp Health Corporation have?
Zepp Health Corporation has 8,460,126 shares outstanding.
What happened to Zepp Health Corporation’s price movement after its last earnings report?
Zepp Health Corporation reported an EPS of -$1.214 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Zepp Health Corporation?
Currently, no hedge funds are holding shares in MX:ZEPPN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Zepp Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-56.24%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
2.67%
Trailing 12-Months
Company Description
Zepp Health Corporation
Headquartered in Hefei, China, and established in 2013, Zepp Health Corporation (known as Huami Corporation until its rebranding in February 2021) is a technology firm specializing in the creation, production, and sale of intelligent wearable devices. Operating predominantly within the People's Republic of China, the company divides its operations into two main segments: Xiaomi Wearable Products and its own-branded products and other ventures. Its diverse product range includes smart bands, watches, and scales, in addition to hearable devices, home fitness equipment like treadmills, sportswear, selected home appliances, and various smartwatch accessories. These offerings are marketed under both the Xiaomi and Amazfit brands. Zepp Health also empowers users with detailed analyses of their collected activity and biometric data, presented through intuitive charts and graphs accessible via its proprietary Zepp Life and Zepp mobile applications.
ZEPPN Company Deck
ZEPPN Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a predominantly positive operational narrative: strong top-line performance with Q1 revenue up 33.8% YoY, meaningful premiumization (ASP +20% YoY), gross profit expansion (up 35.3%) and market share gains supported by new product launches and a strategic 3‑year HYROX partnership. Management also demonstrated progress on expense discipline (operating loss narrowed) and working capital (inventory down). Key near-term challenges include rising memory costs, unfavorable FX impacts, elevated operating expenses from front‑loaded launches/marketing, sequential margin moderation from a Q4 peak, and potential shipment timing risk that could shift revenue across quarters. Overall, the positive revenue, premiumization, margin resilience YoY and strategic partnerships outweigh the challenges, but the company remains on a path toward profitability rather than currently profitable.View all MX:ZEPPN earnings summaries